Logo image of SANG

SANGOMA TECHNOLOGIES CORP (SANG) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SANG - CA80100R4089 - Common Stock

5.04 USD
+0.01 (+0.16%)
Last: 12/17/2025, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, SANG scores 3 out of 10 in our fundamental rating. SANG was compared to 48 industry peers in the Communications Equipment industry. Both the profitability and financial health of SANG have multiple concerns. SANG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SANG had negative earnings in the past year.
SANG had a positive operating cash flow in the past year.
In the past 5 years SANG reported 4 times negative net income.
SANG had a positive operating cash flow in each of the past 5 years.
SANG Yearly Net Income VS EBIT VS OCF VS FCFSANG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

SANG has a Return On Assets of -1.61%. This is comparable to the rest of the industry: SANG outperforms 50.00% of its industry peers.
The Return On Equity of SANG (-2.16%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.61%
ROE -2.16%
ROIC N/A
ROA(3y)-3.39%
ROA(5y)-6.47%
ROE(3y)-5.4%
ROE(5y)-10.77%
ROIC(3y)N/A
ROIC(5y)N/A
SANG Yearly ROA, ROE, ROICSANG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

SANG has a Gross Margin of 69.22%. This is amongst the best in the industry. SANG outperforms 91.67% of its industry peers.
In the last couple of years the Gross Margin of SANG has remained more or less at the same level.
SANG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y1.11%
SANG Yearly Profit, Operating, Gross MarginsSANG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

SANG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SANG has less shares outstanding
Compared to 5 years ago, SANG has more shares outstanding
The debt/assets ratio for SANG has been reduced compared to a year ago.
SANG Yearly Shares OutstandingSANG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
SANG Yearly Total Debt VS Total AssetsSANG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 1.18, we must say that SANG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.18, SANG perfoms like the industry average, outperforming 52.08% of the companies in the same industry.
SANG has a debt to FCF ratio of 1.93. This is a very positive value and a sign of high solvency as it would only need 1.93 years to pay back of all of its debts.
SANG has a better Debt to FCF ratio (1.93) than 64.58% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that SANG is not too dependend on debt financing.
SANG has a Debt to Equity ratio (0.11) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.93
Altman-Z 1.18
ROIC/WACCN/A
WACC8.21%
SANG Yearly LT Debt VS Equity VS FCFSANG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.87 indicates that SANG may have some problems paying its short term obligations.
SANG has a worse Current ratio (0.87) than 95.83% of its industry peers.
SANG has a Quick Ratio of 0.87. This is a bad value and indicates that SANG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SANG (0.72) is worse than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.72
SANG Yearly Current Assets VS Current LiabilitesSANG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

3

3. Growth

3.1 Past

SANG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.00%, which is quite impressive.
Looking at the last year, SANG shows a decrease in Revenue. The Revenue has decreased by -6.97% in the last year.
Measured over the past years, SANG shows a quite strong growth in Revenue. The Revenue has been growing by 19.31% on average per year.
EPS 1Y (TTM)36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y1.79%
Revenue growth 5Y19.31%
Sales Q2Q%-15.51%

3.2 Future

The Earnings Per Share is expected to grow by 52.86% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -4.29% on average over the next years.
EPS Next Y-27.93%
EPS Next 2Y52.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.43%
Revenue Next 2Y-4.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SANG Yearly Revenue VS EstimatesSANG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
SANG Yearly EPS VS EstimatesSANG Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

3

4. Valuation

4.1 Price/Earnings Ratio

SANG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 99.80, SANG can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SANG indicates a slightly more expensive valuation: SANG is more expensive than 62.50% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.58. SANG is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 99.8
SANG Price Earnings VS Forward Price EarningsSANG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

SANG's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SANG is cheaper than 97.92% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SANG indicates a rather cheap valuation: SANG is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.38
EV/EBITDA 4.74
SANG Per share dataSANG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as SANG's earnings are expected to grow with 52.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.86%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SANG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SANGOMA TECHNOLOGIES CORP

NASDAQ:SANG (12/17/2025, 8:00:02 PM)

5.04

+0.01 (+0.16%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)02-03 2026-02-03
Inst Owners34.91%
Inst Owner Change-7.36%
Ins Owners27.21%
Ins Owner ChangeN/A
Market Cap167.03M
Revenue(TTM)227.36M
Net Income(TTM)-5.44M
Analysts82
Price Target7.8 (54.76%)
Short Float %0.1%
Short Ratio4.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)285.64%
Min EPS beat(2)-23.76%
Max EPS beat(2)595.05%
EPS beat(4)1
Avg EPS beat(4)85.56%
Min EPS beat(4)-197.03%
Max EPS beat(4)595.05%
EPS beat(8)2
Avg EPS beat(8)30.1%
EPS beat(12)4
Avg EPS beat(12)5.37%
EPS beat(16)6
Avg EPS beat(16)-259.19%
Revenue beat(2)1
Avg Revenue beat(2)-0.06%
Min Revenue beat(2)-0.46%
Max Revenue beat(2)0.34%
Revenue beat(4)1
Avg Revenue beat(4)-2.55%
Min Revenue beat(4)-7.66%
Max Revenue beat(4)0.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.95%
Revenue beat(12)3
Avg Revenue beat(12)-2.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.19%
PT rev (1m)0.33%
PT rev (3m)-5.97%
EPS NQ rev (1m)-46.67%
EPS NQ rev (3m)-46.67%
EPS NY rev (1m)-58.33%
EPS NY rev (3m)-522.22%
Revenue NQ rev (1m)0.62%
Revenue NQ rev (3m)-13.61%
Revenue NY rev (1m)0.39%
Revenue NY rev (3m)-14.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 99.8
P/S 0.73
P/FCF 6.38
P/OCF 4.83
P/B 0.66
P/tB N/A
EV/EBITDA 4.74
EPS(TTM)-0.16
EYN/A
EPS(NY)0.05
Fwd EY1%
FCF(TTM)0.79
FCFY15.67%
OCF(TTM)1.04
OCFY20.71%
SpS6.86
BVpS7.59
TBVpS-0.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.61%
ROE -2.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.22%
FCFM 11.51%
ROA(3y)-3.39%
ROA(5y)-6.47%
ROE(3y)-5.4%
ROE(5y)-10.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y1.11%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.93
Debt/EBITDA 0.67
Cap/Depr 18.9%
Cap/Sales 3.71%
Interest Coverage N/A
Cash Conversion 81.28%
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.72
Altman-Z 1.18
F-Score5
WACC8.21%
ROIC/WACCN/A
Cap/Depr(3y)22.92%
Cap/Depr(5y)19.53%
Cap/Sales(3y)4.2%
Cap/Sales(5y)3.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y-27.93%
EPS Next 2Y52.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y1.79%
Revenue growth 5Y19.31%
Sales Q2Q%-15.51%
Revenue Next Year-12.43%
Revenue Next 2Y-4.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-112.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2297.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.51%
FCF growth 3Y27.36%
FCF growth 5Y36.51%
OCF growth 1Y12.7%
OCF growth 3Y25.66%
OCF growth 5Y36.31%

SANGOMA TECHNOLOGIES CORP / SANG FAQ

What is the fundamental rating for SANG stock?

ChartMill assigns a fundamental rating of 3 / 10 to SANG.


Can you provide the valuation status for SANGOMA TECHNOLOGIES CORP?

ChartMill assigns a valuation rating of 3 / 10 to SANGOMA TECHNOLOGIES CORP (SANG). This can be considered as Overvalued.


What is the profitability of SANG stock?

SANGOMA TECHNOLOGIES CORP (SANG) has a profitability rating of 3 / 10.


Can you provide the financial health for SANG stock?

The financial health rating of SANGOMA TECHNOLOGIES CORP (SANG) is 3 / 10.